Collegium Pharmaceutical Inc (COLL)

[floblu14]

January 28, 2022
A Form SC 13G/A has been filed with the United States Securities and Exchange Commission.
View this filing ?
https://ir.collegiumpharma.com/static-files/a1aa0b3b-4a52-4c4d-92c6-c056887cc664

BlackRock, Inc. now owns 5550301 shares or 16.3% of Collegium

What Can a Schedule 13D Tell an Investor?

A Schedule 13D is a document that must be filed with the Securities and Exchange Commission (SEC) within 10 days of the purchase of more than 5% of the shares of a public company by anyone investor or entity. It is sometimes referred to as a beneficial ownership report.1?

This document, which is publicly available, provides useful information about majority ownership in the company. It reveals the name, ownership amount, and stated intentions of any investor who has purchased a substantial share of a company.2? (The buyer might not intend an outright takeover. It might, for example, be a purchase by an activist investor seeking more management input.)

KEY TAKEOVERS
The Schedule 13D is a required SEC filing for entities acquiring more than 5% of the stock of a public company.

It is seen as a signal of an imminent corporate takeover.

Significant information in the 13D includes the source of the funds used for the purchase.1?

Read more:
https://www.investopedia.com/ask/answers/09/schedule-13d.asp